Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by down-regulating PI3K/AKT, JAK2/STAT3 and NF-κB signalling pathways.
- DOI
- 10.1080/21691401.2019.1634084
- Published
- 2019 Dec
- Container
- Artificial cells, nanomedicine, and biotechnology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/21691401.2019.1634084,
title = {Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by down-regulating PI3K/AKT, JAK2/STAT3 and NF-κB signalling pathways.},
author = {Yang Y and Zhao J and Song X and Li L and Li F and Shang J and Wang WW},
year = {2019},
journal = {Artificial cells, nanomedicine, and biotechnology},
doi = {10.1080/21691401.2019.1634084},
url = {https://doi.org/10.1080/21691401.2019.1634084}
}RIS
TY - JOUR TI - Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by down-regulating PI3K/AKT, JAK2/STAT3 and NF-κB signalling pathways. AU - Yang Y AU - Zhao J AU - Song X AU - Li L AU - Li F AU - Shang J AU - Wang WW PY - 2019 JO - Artificial cells, nanomedicine, and biotechnology DO - 10.1080/21691401.2019.1634084 UR - https://doi.org/10.1080/21691401.2019.1634084 ER -
APA
Y, Y., J, Z., X, S., L, L., F, L., J, S., & WW, W. (2019). Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by down-regulating PI3K/AKT, JAK2/STAT3 and NF-κB signalling pathways.. Artificial cells, nanomedicine, and biotechnology. https://doi.org/10.1080/21691401.2019.1634084
Source records
- pubmed · retrieved 2026-09-25T15:20:40.920Z